Santini Massimo, Russo Maurizio, Botto Gianluca, Lunati Maurizio, Proclemer Alessandro, Schmidt Boris, Erdogan Ali, Helmling Erhard, Rauhe Werner, Desaga Martin, Santi Elisabetta, Messier Marc, Boriani Giuseppe
Cardiovascular Department, San Filippo Neri Hospital, Via Martinotti, 20, 00135 Roma, Italy.
Europace. 2009 Apr;11(4):476-82. doi: 10.1093/europace/eun349. Epub 2009 Jan 9.
To evaluate clinical and arrhythmic outcomes in post-infarction cardiomyopathy patients implanted with a defibrillator (ICD) for primary prevention of sudden death.
The SEARCH-MI registry is a European multi-centre, prospective, observational study enrolling patients after myocardial infarction, chronic left ventricular dysfunction and an ICD implanted for primary prevention of sudden death. Data on 556 patients with at least one recorded follow-up are presented. Survey to Evaluate Arrhythmia Rate in High-risk MI (SEARCH-MI) patients were sicker than those enrolled in MADIT-II with higher New York Heart Association class and left bundle branch block. Total mortality was 10.4%. Close to one-third (30%) of patients experienced episodes of sustained ventricular arrhythmia. One-quarter (23%) received at least one appropriate therapy and 10% inappropriate therapy. Gender (25% males vs. 5% females, P = 0.0009) and history of non-sustained ventricular tachycardia (24% with vs. 18% without P = 0.037) were predictive of appropriate ventricular therapy.
SEARCH-MI represents the current clinical management of post-MI patients with left ventricular dysfunction indicated to defibrillator implant for primary prevention. European routine clinical practice was influenced by landmark trials and guidelines which impacted on the implantation of cardiac resynchronization therapy in over 25% of such patients. Non-sustained ventricular tachycardia identifies subjects with a higher incidence of appropriate ICD therapy.
评估因心肌梗死后心肌病而植入除颤器(ICD)进行心脏性猝死一级预防的患者的临床及心律失常结局。
SEARCH-MI注册研究是一项欧洲多中心、前瞻性、观察性研究,纳入心肌梗死后、慢性左心室功能不全且植入ICD进行心脏性猝死一级预防的患者。本文呈现了556例至少有一次随访记录患者的数据。评估高危心肌梗死(SEARCH-MI)患者心律失常发生率的调查显示,这些患者比参加MADIT-II研究的患者病情更重,纽约心脏协会心功能分级更高,且存在左束支传导阻滞。总死亡率为10.4%。近三分之一(30%)的患者发生持续性室性心律失常。四分之一(23%)的患者接受了至少一次恰当治疗,10%接受了不恰当治疗。性别(男性25% 对女性5%,P = 0.0009)和非持续性室性心动过速病史(有非持续性室性心动过速病史者为24%,无此病史者为18%,P = 0.037)是恰当心室治疗的预测因素。
SEARCH-MI代表了心肌梗死后左心室功能不全、适合植入除颤器进行一级预防的患者的当前临床管理情况。欧洲的常规临床实践受到标志性试验和指南的影响,这些试验和指南使超过25%的此类患者接受了心脏再同步治疗。非持续性室性心动过速提示患者接受恰当ICD治疗的发生率较高。